Nandan Padukone

Amministratore Delegato presso ImmunoMolecular Therapeutics, Inc.

Health Technology

Profilo

Nandan Padukone is currently the Chief Executive Officer at ImmunoMolecular Therapeutics, Inc. Prior to this, he worked as the Senior Vice President-Innovations at Joslin Diabetes Center, Inc.

Posizioni attive di Nandan Padukone

Società	Posizione	Inizio
ImmunoMolecular Therapeutics, Inc. ImmunoMolecular Therapeutics, Inc. BiotechnologyHealth Technology ImmunoMolecular Therapeutics LLC develops and manufactures immuno-therapeutic drugs for autoimmune diseases. The firm offers oral small molecule that starves the autoimmune process in type 1 diabetes by blocking DQ8 on specific immune cells. The company was founded by Steve Orndorff, Aaron Michels, and Peter Gottlieb in 2015 and is headquartered in Broomfield, CO.	Amministratore Delegato	-

Tutte le posizioni attive di Nandan Padukone

Precedenti posizioni note di Nandan Padukone

Società	Posizione	Fine
Joslin Diabetes Center, Inc. Joslin Diabetes Center, Inc. Pharmaceuticals: MajorHealth Technology Joslin Diabetes Center, Inc. is a non-profit organization, which engages in the development of pharmaceuticals for diabetes. It provides adult care, pediatric care, eye care, and education programs and classes. The company was founded by Elliott P. Joslin in 1893 and is headquartered in Boston, MA.	Corporate Officer/Principal	02/01/1990

Vedi nel dettaglio l'esperienza di Nandan Padukone

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Nandan Padukone

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
Joslin Diabetes Center, Inc. Joslin Diabetes Center, Inc. Pharmaceuticals: MajorHealth Technology Joslin Diabetes Center, Inc. is a non-profit organization, which engages in the development of pharmaceuticals for diabetes. It provides adult care, pediatric care, eye care, and education programs and classes. The company was founded by Elliott P. Joslin in 1893 and is headquartered in Boston, MA.	Health Technology
ImmunoMolecular Therapeutics, Inc. ImmunoMolecular Therapeutics, Inc. BiotechnologyHealth Technology ImmunoMolecular Therapeutics LLC develops and manufactures immuno-therapeutic drugs for autoimmune diseases. The firm offers oral small molecule that starves the autoimmune process in type 1 diabetes by blocking DQ8 on specific immune cells. The company was founded by Steve Orndorff, Aaron Michels, and Peter Gottlieb in 2015 and is headquartered in Broomfield, CO.	Health Technology